Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Gains from Sales and Divestitures: 2014-2024

Historic Gains from Sales and Divestitures for Ptc Therapeutics (PTCT) over the last 7 years, with Dec 2024 value amounting to $963,543.

  • Ptc Therapeutics' Gains from Sales and Divestitures rose 29.99% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 29.99%. This contributed to the annual value of $963,543 for FY2024, which is 4.68% up from last year.
  • As of FY2024, Ptc Therapeutics' Gains from Sales and Divestitures stood at $963,543, which was up 4.68% from $920,488 recorded in FY2023.
  • In the past 5 years, Ptc Therapeutics' Gains from Sales and Divestitures ranged from a high of $963,543 in FY2024 and a low of $232,975 during FY2020.
  • Over the past 3 years, Ptc Therapeutics' median Gains from Sales and Divestitures value was $920,488 (recorded in 2023), while the average stood at $796,294.
  • Data for Ptc Therapeutics' Gains from Sales and Divestitures shows a peak YoY soared of 82.33% (in 2023) over the last 5 years.
  • Over the past 5 years, Ptc Therapeutics' Gains from Sales and Divestitures (Yearly) stood at $232,975 in 2020, then spiked by 43.84% to $335,114 in 2021, then spiked by 50.65% to $504,851 in 2022, then spiked by 82.33% to $920,488 in 2023, then rose by 4.68% to $963,543 in 2024.